SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001615219-22-000124
Filing Date
2022-08-05
Accepted
2022-08-05 15:59:19
Documents
46
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q flks-20220630.htm   iXBRL 10-Q 694672
2 EX-31.1 slrx20220630ex-311.htm EX-31.1 8963
3 EX-31.2 slrx20220630ex-312.htm EX-31.2 8761
4 EX-32.1 slrx20220630ex-321.htm EX-32.1 6444
  Complete submission text file 0001615219-22-000124.txt   3251809

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT flks-20220630.xsd EX-101.SCH 19996
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT flks-20220630_cal.xml EX-101.CAL 28607
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT flks-20220630_def.xml EX-101.DEF 94905
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT flks-20220630_lab.xml EX-101.LAB 323776
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT flks-20220630_pre.xml EX-101.PRE 197520
40 EXTRACTED XBRL INSTANCE DOCUMENT flks-20220630_htm.xml XML 416202
Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Filer) CIK: 0001615219 (see all company filings)

IRS No.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36812 | Film No.: 221140644
SIC: 2834 Pharmaceutical Preparations